share_log

HC Wainwright & Co. Reiterates Buy on AEON Biopharma, Maintains $18 Price Target

Benzinga ·  May 6 06:44

HC Wainwright & Co. analyst Douglas Tsao reiterates AEON Biopharma (AMEX:AEON) with a Buy and maintains $18 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment